John Kloetzing
Owner & Managing Director, Kloetzing Transformation Partners UG
John Kloetzing
Owner & Managing Director, Kloetzing Transformation Partners UG
John Kloetzing is a supply chain transformation leader with more than 13 years of experience across pharmaceuticals and consumer goods. He has led international planning, S&OP and business transformation initiatives across Europe, North America and Asia, combining strategic direction with hands-on execution. His work focuses on building decision-ready organizations, strengthening cross-functional collaboration and translating complexity into clear operational choices. John has held senior roles at Bayer and Heineken and has extensive experience in scenario planning, integrated business planning, launch readiness and digital transformation. He is currently completing a Global MBA at ESMT Berlin and is the founder of Kloetzing Transformation Partners, advising organizations on supply chain strategy, AI-enabled decision architecture and leadership under uncertainty.
Vera Hazelwood
Director, Data Science Collaborative Programmes, AstraZeneca
Vera Hazelwood
Director, Data Science Collaborative Programmes, AstraZeneca
Vera H is a Learning & HR Technology professional with expertise in human resources, talent development, and HR digital transformation. She currently works at PT Sinergy Informasi Pratama, where she focuses on enhancing HR information systems, leveraging AI-driven solutions, and supporting organizational development initiatives. With a background in psychology and data analytics, Vera combines people-centric strategies with technology to improve workforce performance and business outcomes. Her experience spans talent acquisition, learning and development, HR operations, and process improvement. Passionate about continuous learning, she is committed to building innovative HR practices, driving organizational growth, and creating data-informed solutions that support both employee development and long-term business success.
Ashish Chandra Saxena
Global Capability Owner (GCO)- Customer Targeting & Engagement Planning, Boehringer Ingelheim
Ashish Chandra Saxena
Global Capability Owner (GCO)- Customer Targeting & Engagement Planning, Boehringer Ingelheim
With over three decades of extensive international experience in the pharmaceutical industry, Ashish Saxena has held diverse leadership roles across Sales, Training, Sales Force Effectiveness, Commercial Excellence, Digital Transformation, Market Research and Analytics. His career encompasses both operational execution and strategic leadership, fostering a comprehensive and multidimensional expertise in pharmaceutical business complex landscape. Currently based in Germany, Ashish works as the Global Capability Owner at Boehringer Ingelheim, where he leads the global function for Customer Targeting and Engagement Planning. In this role, he is responsible for shaping the global vision and strategy, collaborating with regional and country teams worldwide. He spearheads cross-functional initiatives to develop frameworks, processes, and tools that enable effective segmentation, targeting, and engagement of healthcare professionals (HCPs) and healthcare organizations (HCOs), ensuring alignment with evolving healthcare landscapes and the dynamic business environment.
Serena Saggini
Director, Sophos Biotech
Serena Saggini
Director, Sophos Biotech
A Harvard-graduated Director, she boasts over 25 years of exceptional commercial success in Biotech, Rare Diseases, Oncology, and CNS across top-tier pharma leaders like Sanofi, Genzyme, GSK, and Ferring. Recognized for a highly innovative approach, she pioneers AI-driven market analysis and builds high-performing business units from scratch. Her career is anchored in absolute patient-centricity, demonstrated by a proven track record of forging strong partnerships with patient associations, institutions and scientific societies. Honored of the 2026 Leadership Excellence Award, she practices 360-degree leadership that bridges cross-functional teamwork with strategic/commercial growth. She is also regular keynote speaker at prestigious global digital and commercial excellence summits.
Denis Morgenthaler
Transformation Architect, Bayer AG
Denis Morgenthaler
Transformation Architect, Bayer AG
With over 24 years in pharmaceuticals and industry, I am a purpose-driven leader dedicated to patient impact and organizational transformation.
Following early experience at Volkswagen and Accenture, I spent over two decades at Bayer Pharma, advancing from CDMO procurement to leading global supply management for Biotech, Radiology, and Steriles & Devices across Berlin, Basel, Barcelona, and Pittsburgh.
Since 2023 I serve as a Dynamic Shared Ownership (DSO) Transformation Architect, designing agile operating models that empower networked teams.
Additionally, as a Lecturer in Practice at Quadriga University Berlin, I bridge industry and academia—teaching supply chain / operations management , business / digital transformation and executive leadership.
Hiram Baker
CEO/Founder, Baker Industries LLC
Hiram Baker
CEO/Founder, Baker Industries LLC
Hiram Baker is an experienced business leader and the Chief Executive Officer of Baker Industries L.L.C., an operations consulting firm focused on providing comprehensive solutions across funding, real estate, executive staffing, investments, technology, marketing, and strategic growth initiatives for businesses of all sizes. In his role, Hiram leverages extensive client and partner relationships to drive business development, operational excellence, and innovative problem-solving strategies. With a strong entrepreneurial mindset, he guides Baker Industries in delivering tailored support that enhances organizational performance and accelerates growth outcomes. His background reflects a commitment to scalable, client-centric service and the development of unique approaches to complex business challenges.
George Lellis
CFCIM, FIDM, Optimark
George Lellis
CFCIM, FIDM, Optimark
George Lellis is an innovator at heart, embracing AI long before the AI has been known to the world; his always-on curiosity at the physicians' rooms led him to understand how the sales reps are working and talking with them. Being an accomplished global marketing strategist and AI transformation consultant with experience on multiple fronts in Fortune 500 consumer goods, pharma and medtech companies across EMEA, LATAM, APAC & Americas, he can join the dots between data, product and 360-degree growth. His consultative sales background made him specialise in commercial strategy, portfolio management, international business and transformational programme leadership, advising CMO and VP-level commercial leaders at prominent market players. George holds a Chartered Postgraduate Diploma in Marketing from the Chartered Institute of Marketing, a MSc. Econs. In Digital Media and Communications from the London School of Economics, and carries CFCIM, FIDM and Agile delivery (SAFe & Prince2) accreditations. His consulting work spans marketing strategy, brand strategy, AI product strategy, customer experience-led operating models, commercial AI, data analytics, and strategic communications. He is a frequent guest speaker and panel moderator in leading marketing, technology, and life sciences events. George's DNA could have led him to become an internist but preferred to diagnose and propose treatment plans for businesses instead of patients.
Michael Dreiseidler, PhD
Medical Affairs Lead, Novartis
Michael Dreiseidler, PhD
Medical Affairs Lead, Novartis
Michael Dreiseidler, PhD, is a senior Medical Affairs leader with more than 12 years of experience in the pharmaceutical industry across clinical operations and medical affairs. He currently works in hematology, with a particular focus on evidence strategy, scientific engagement and the translation of clinical evidence into meaningful impact in patient care. Over the course of his career, Michael has held roles spanning clinical research, field medical and medical strategy, giving him a broad perspective on how evidence is generated, interpreted and ultimately applied in clinical practice. His current interests include real-world evidence, evidence gap identification, implementation science and the distinction between evidence required for regulatory or HTA purposes and evidence needed to support clinical adoption and decision-making.